Literature DB >> 20626438

Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Experience of over 18,000 FNAs reported at the same institution during 1998-2007.

S Piana1, A Frasoldati, M Ferrari, R Valcavi, E Froio, V Barbieri, C Pedroni, G Gardini.   

Abstract

OBJECTIVE: Fine needle aspiration (FNA) has long been recognized as an essential technique for the evaluation of thyroid nodules. Although specific cytological patterns have been recognized, a wide variety of reporting schemes for thyroid FNA results have been adopted. This study reports our experience with a five-category reporting scheme developed in-house based on a numeric score and applied to a large series of consecutive thyroid FNAs. It focuses mainly on the accuracy of thyroid FNA as a preoperative test in a large subset of histologically distinct thyroid lesions.
METHODS: During the 1998-2007 period, 18,359 thyroid ultrasound-guided FNAs were performed on 15,269 patients; FNA reports were classified according to a C1-C5 reporting scheme: non-diagnostic (C1), benign (C2), indeterminate (C3), suspicious (C4), and malignant (C5).
RESULTS: Non-diagnostic (C1) and indeterminate (C3) FNA results totalled 2,230 (12.1%) and 1,461 (7.9%), respectively, while suspicious (C4) and malignant (C5) results totalled 238 (1.3%) and 531 (2.9%), respectively. Histological results were available in 2,047 patients, with thyroid malignancy detected in 840. Positive predictive value of FNA was 98.1% with a 49.0 likelihood ratio (LR) of malignancy in patients with a C4/C5 FNA report.
CONCLUSIONS: This five-category scheme for thyroid FNA is accurate in discriminating between the virtual certainty of malignancy associated with C5, a high rate (92%) of malignancy associated with C4, and a 98% probability of a histological benign diagnosis associated with C2. Further sub-classifications of C3 may improve the accuracy of the diagnostic scheme and may help in recognizing patients eligible for a 'wait and see' management.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20626438     DOI: 10.1111/j.1365-2303.2010.00777.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  14 in total

Review 1.  Cytopathologic diagnosis of fine needle aspiration biopsies of thyroid nodules.

Authors:  Evangelos P Misiakos; Niki Margari; Christos Meristoudis; Nickolas Machairas; Dimitrios Schizas; Konstantinos Petropoulos; Aris Spathis; Petros Karakitsos; Anastasios Machairas
Journal:  World J Clin Cases       Date:  2016-02-16       Impact factor: 1.337

2.  Review of atypical cytology of thyroid nodule according to the Bethesda system and its beneficial effect in the surgical treatment of papillary carcinoma.

Authors:  Yoo Seung Chung; Changyoung Yoo; Ji Han Jung; Hyun Joo Choi; Young-Jin Suh
Journal:  J Korean Surg Soc       Date:  2011-08-03

3.  Italian consensus for the classification and reporting of thyroid cytology.

Authors:  Francesco Nardi; Fulvio Basolo; Anna Crescenzi; Guido Fadda; Andrea Frasoldati; Fabio Orlandi; Lucio Palombini; Enrico Papini; Michele Zini; Alfredo Pontecorvi; Paolo Vitti
Journal:  J Endocrinol Invest       Date:  2014-05-01       Impact factor: 4.256

4.  Pathological findings of thyroid nodules after percutaneous laser ablation : a series of 22 cases with cyto-histological correlation.

Authors:  Simonetta Piana; Fabrizio Riganti; Elisabetta Froio; Massimiliano Andrioli; Claudio M Pacella; Roberto Valcavi
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

Review 5.  Pitfalls in Thyroid Cytopathology.

Authors:  Esther Diana Rossi; Adebowale J Adeniran; William C Faquin
Journal:  Surg Pathol Clin       Date:  2019-12

6.  Diagnostic value of BRAF (V600E)-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis.

Authors:  Xingyun Su; Xiaoxia Jiang; Xin Xu; Weibin Wang; Xiaodong Teng; Anwen Shao; Lisong Teng
Journal:  Onco Targets Ther       Date:  2016-04-27       Impact factor: 4.147

7.  Promise and pitfalls of molecular markers of thyroid nodules.

Authors:  S Jadhav; Anurag Lila; Tushar Bandgar; Nalini Shah
Journal:  Indian J Endocrinol Metab       Date:  2012-12

8.  Malignancy risk analysis in patients with inadequate fine needle aspiration cytology (FNAC) of the thyroid.

Authors:  Talib Al Maqbali; Miroslav Tedla; Martin O Weickert; Hisham Mehanna
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  A putative OTU domain-containing protein 1 deubiquitinating enzyme is differentially expressed in thyroid cancer and identifies less-aggressive tumours.

Authors:  A P Carneiro; C F Reis; E C Morari; Y C P Maia; R Nascimento; J M C Bonatto; M A de Souza; L R Goulart; L S Ward
Journal:  Br J Cancer       Date:  2014-06-17       Impact factor: 7.640

Review 10.  A Different Perspective on Evaluating the Malignancy Rate of the Non-Diagnostic Category of the Bethesda System for Reporting Thyroid Cytopathology: A Single Institute Experience and Review of the Literature.

Authors:  Pembegul Gunes; Sule Canberk; Mine Onenerk; Murat Erkan; Nilufer Gursan; Emine Kilinc; Gamze Zeynep Kilicoglu
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.